The role of FASL gene polymorphism (rs: 763110), its serum level and IL21 level with incidence of psoriasis in Iraqi patients

Abstract

Psoriasis is a chronic, immune-mediated skin disease with systemic pro-inflammatory can defined by keratinocyte hyper proliferation. FASL gene cell surface death receptor which is important in apoptosis mediated by cytotoxic T cells and natural killer cells. The goals of current study is design to investigate genotyping of the FASL gene (Fas ligand gene) -844 T>C (rs:763110), evaluate its serum level and to estimate level of IL-21correlated with incidence of psoriasis in Iraqi patients. 100 blood samples collected from December 2022 to February 2023, blood samples split into two groups first 50 psoriasis patients (30 males and 20 females) with age range (17-66years) and second group 50 Apparently healthy as control group (24 males 26 females) with age range (20-60 years) visit the Al-Yarmouk Teaching Hospital’s Department of Dermatology in Iraq/Baghdad. (HRM–PCR) Technique was use for the investigation of gene polymorphism of the FASL gene (rs763110). While EIISA technique used to estimate serum level of each FASL gene and IL-21 in serum. The result of FASL gene polymorphism revealed that there are three genotype (TT),(TC),(CC). There was no significant difference, between (TC) and (CC) genotype In the FASLG -844 and between the psoriasis and control groups. Moreover there was correlation between genotyping and serum level for FASL (rs763110) gene in that (TC) genotype serum level show significant different from (CC) genotype serum level with p-value (P≤0.05) as well as the FASL serum level in patient which represent high significantly different between psoriasis patients when compared to the healthy controls with p-value (P≤0.01). While result of IL21 serum level in psoriasis patients revealed high significant different with p-value (P≤0.01) vs healthy control with high significant different in sever psoriatic patient vs mild and healthy control with p value (P≤0.01).